Immunai
Shir Marom is a seasoned professional currently serving as the Director at Schusterman Family Investments since January 2020. In addition, Shir holds multiple investor roles across various companies, including Q.ai and Monetas.club, both as an active investor and co-founder since 2022, and engagements with Invisible Universe, Navina, retrain.ai, Voyantis, Simply, Syng, and Immunai, all of which commenced between 2021 and 2022. Shir's academic background includes an Executive MBA from Northwestern University’s Kellogg School of Management, a Directors and Senior Executives Program from Tel-Aviv University, and a BA in Government, Diplomacy and Strategy from Reichman University.
This person is not in any teams
This person is not in any offices
Immunai
2 followers
Immunai is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes.